Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1127studies shown
Showing 1,076-1,100 of 1,127
CompletedNCT01106430

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

This study exists to better understand the safety of a therapy or guided support program and how manageable it feels in practice. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.

ADHDOtherFrom 6 Years to 17 Years
Countries
Belgium, Canada, Germany, Hungary, Italy, Poland, Spain, Sweden, United Kingdom, United States
Sponsor
Shire
Condition
ADHD
CompletedNCT01328756

Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

ADHDOtherFrom 6 Years to 17 Years
Countries
Belgium, Germany, Hungary, Italy, Netherlands, Poland, Romania, Spain, Sweden, United Kingdom
Sponsor
Shire
Condition
ADHD
CompletedNCT01183234

SPD544 High Strength Bioequivalence Study

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

ADHDOtherFrom 18 Years to 55 Years
Countries
United Kingdom
Sponsor
Shire
Condition
ADHD
CompletedNCT00784654

Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17

This study exists to understand how the medication LDX holds up over time after the earliest research stage. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.

ADHDOtherFrom 6 Years to 17 Years
Countries
Belgium, France, Germany, Hungary, Italy, Poland, Sweden, United Kingdom, United States
Sponsor
Shire
Condition
ADHD
CompletedNCT02249299

Experimental Medicine in ADHD - Cannabinoids

This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 55 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
ADHD
CompletedNCT03371810

Prevention of Comorbid Depression and Obesity in Attention-deficit/ Hyperactivity Disorder

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 14 Years to 45 Years
Countries
Germany, Netherlands, Spain, United Kingdom
Sponsor
Goethe University
Condition
Depression
CompletedNCT03709940

Brain Connectivity in Attention Deficit Hyperactivity Disorder (ADHD)

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 45 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
ADHD
CompletedNCT02911194

a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD)

This study exists to compare options and see whether questionnaires and follow-up reports offers something meaningfully different. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 5 Years to 10 Years
Countries
United Kingdom
Sponsor
Northumbria University
Condition
ADHD
CompletedNCT01470261

Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 5 Years to 17 Years
Countries
Germany, Hungary, Italy, United Kingdom
Sponsor
NHS Tayside
Condition
ADHD
CompletedNCT02209116

Assessing QbTest Utility in ADHD: A Randomised Controlled Trial

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 6 Years to 17 Years
Countries
United Kingdom
Sponsor
University of Nottingham
Condition
ADHD
CompletedNCT01098058

Cognitive-Behavioural Therapy (CBT) for Adult Attention Deficit Hyperactivity Disorder (ADHD)

This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
South London and Maudsley NHS Foundation Trust
Condition
ADHD
CompletedNCT00700427

A Long Term Study of a Medication for Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 50 Years
Countries
Austria, Belgium, Finland, France, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, United Kingdom
Sponsor
Eli Lilly and Company
Condition
ADHD
CompletedNCT00714688

A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder

This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

ADHDOtherFrom 18 Years to 65 Years
Countries
Belgium, Denmark, Finland, France, Germany, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
Sponsor
Janssen-Cilag International NV
Condition
ADHD
TerminatedISRCTN93360820

Enhancing cognition in bipolarity

This public ISRCTN record appears to relate to bipolarity. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

BipolarityOtherOver 18 Years
Countries
United Kingdom
Sponsor
Suffolk Mental Health Partnership NHS Trust (UK)
Condition
Bipolarity
TerminatedISRCTN45002938

A random controlled trial to compare the efficacy of a brief psycho-educational programme with standard care plus biblio-therapy for individuals with Bipolarity at high risk for relapse.

This public ISRCTN record appears to relate to bipolarity. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

BipolarityOther
Countries
United Kingdom
Sponsor
Department of Health
Condition
Bipolarity
RecruitingISRCTN62698625

FAD - Food for ADHD and Depression

This public ISRCTN record appears to relate to depression. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

DepressionOtherFrom 18 Years to 99 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Depression
RecruitingISRCTN16119301

Creative psychotherapy for depression, Arts for the Blues

This public ISRCTN record appears to relate to depression. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

DepressionOtherFrom 18 Years to 110 Years
Countries
United Kingdom
Sponsor
University of Salford
Condition
Depression
SuspendedISRCTN11185706

Problem adaptation therapy for depression in dementia (PATHFINDER)

This public ISRCTN record appears to relate to depression. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

DepressionOther
Countries
United Kingdom
Sponsor
NOCLOR
Condition
Depression
TerminatedISRCTN11696836

Maternal moments

This public ISRCTN record appears to relate to anxiety. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

AnxietyOtherFrom 18 Years to 45 Years
Countries
United Kingdom
Sponsor
Goldsmiths, University of London
Condition
Anxiety
TerminatedISRCTN49546767

Identifying depression in older patients in the emergency department

This public ISRCTN record appears to relate to depression. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

DepressionOther
Countries
United Kingdom
Sponsor
Salford Royal NHS Foundation Trust
Condition
Depression
TerminatedISRCTN16896708

Sing to Your Bump

This public ISRCTN record appears to relate to anxiety. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.

AnxietyOtherFrom 18 Years to 45 Years
Countries
United Kingdom
Sponsor
Goldsmiths, University of London
Condition
Anxiety
United Kingdom | Clinical Trials | HopeStage Research